JONBUR Research · Initiation
You're reading an earlier report from Oct 20, 2026. See the latest report
KC · 029460 · Medical & precision devices
KC: Low Multiples and Steady Revenue as Sale Headlines Emerge
Why this report
Start of coverage: written when a reader opened this company and there was no report yet.
KC closed at ₩37,600 on 2026-10-19, up 35.7% over three months but down 9.0% over one month, with a market cap of ₩414.4B. News on 2026-10-16 reports a consortium selected as preferred bidder for a ₩300B deal, while the data shows trailing multiples well below the listed peers.
Written Oct 20, 2026 · Data as of Oct 19, 2026 · 0 views
This is not financial advice. The report does not recommend buying or selling anything.
Thesis
The data supports a picture of a company trading at low multiples (P/E 7.6, P/B 0.4, EV/EBITDA 5.0) with modest profitability (ROE 6.3%) and a very light balance sheet. Foreign ownership rose from 11.7% to 14.5% over 60 days, and filings show several shareholding reports and changes in the largest shareholder's holdings. Two headlines from 2026-10-16 mention a consortium selected as preferred bidder for an acquisition valued at ₩300B. The data does not give the terms, the stake involved, the timing or whether the deal will complete, so the news cannot be assessed further. The model estimate sits below the current price, while the low multiples point the other way, so the evidence is mixed.
Business overview
KC is listed on KOSPI and classified in medical and precision devices. It was founded in 1987 and listed in 1997, with 11,020,535 listed shares and two co-CEOs. Trailing revenue to H1 2026 was ₩814.0B. Annual revenue was ₩553.8B in 2021, ₩858.0B in 2022 (up 54.9%), ₩727.0B in 2023 (down 15.3%), ₩738.5B in 2024 (up 1.6%) and ₩797.3B in 2025 (up 8.0%). One headline describes the company as a marine parts maker, which the sector data does not clarify.
Every earlier JONBUR Research report and update note on KC, with Pro.
Unlock with ProModel estimate of fair value
- Bear
- ₩5,998
- -84%
- Base
- ₩22,540
- -38%
- Bull
- ₩51,589
- +41%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Base case of the 5-year discounted cash flow model on the stock's Valuation tab (statements TTM to H1 2026; discount rate 7.9%). Bear and Bull move the main assumptions by fixed steps. See and change the assumptions
Filings and data used
- Insider shareholding reportAug 31, 2026
- Insider shareholding reportAug 31, 2026
- 5%+ holding reportAug 31, 2026
- 5%+ holding reportAug 31, 2026
- 5%+ holding reportAug 31, 2026
- Change in largest shareholder's holdingsAug 24, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- Preliminary earnings (consolidated)Aug 6, 2026
- 5%+ holding reportJul 31, 2026
- Trading Plan Report for Executives and Major Shareholders' Specific SecuritiesJul 24, 2026
- Trading Plan Report for Executives and Major Shareholders' Specific SecuritiesJul 24, 2026
- Change in largest shareholder's holdingsJul 14, 2026
- TrueBlue and Envester pursue ₩300B acquisition of marine parts maker KCOct 16, 2026
- [MM] KC, valued at ₩300B, selects NVESTER-TrueBlue consortium as preferred bidderOct 16, 2026
- Daily prices up to 2026-10-19
- Financial statements, trailing 12 months as of H1 2026
- Our fair value model, statements as of TTM to H1 2026
Report history
Source: KRX statistical information